Matter Number: 151–0202 Related Federal Register Notice: Lupin Ltd., Gavis Pharmaceuticals LLC, and Novel Laboratories Inc.; Analysis to Aid Public Comment (February 25, 2016) Comments 1.K Sanders - Mar 14, 2016 #00003 2.Alicja Pachwicewicz - Feb 19, 2016 #00001 Comments From Members of Congress
Comments